These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 8539180)
1. The role of cladribine in the treatment of lymphoid malignancies. Nelson MC; Hogan DK Oncol Nurs Forum; 1995 Oct; 22(9):1395-400. PubMed ID: 8539180 [TBL] [Abstract][Full Text] [Related]
2. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia. Rai KR Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325 [TBL] [Abstract][Full Text] [Related]
3. 2-Chlorodeoxyadenosine, a "novel" agent in the treatment of both lymphoid and myeloid malignancies. Lauria F Haematologica; 1992; 77(6):443-5. PubMed ID: 1363233 [No Abstract] [Full Text] [Related]
4. [Treatment of hairy cell leukemia with cladribine]. Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550 [TBL] [Abstract][Full Text] [Related]
5. Cladribine: from the bench to the bedside--focus on hairy cell leukemia. Greyz N; Saven A Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311 [TBL] [Abstract][Full Text] [Related]
6. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia. Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592 [No Abstract] [Full Text] [Related]
7. [Cladribine]. Ogura M Gan To Kagaku Ryoho; 2003 Feb; 30(2):309-17. PubMed ID: 12610885 [TBL] [Abstract][Full Text] [Related]
8. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine). Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889 [TBL] [Abstract][Full Text] [Related]
10. Beyond hairy cell: the activity of cladribine in other hematologic malignancies. Sigal DS; Miller HJ; Schram ED; Saven A Blood; 2010 Oct; 116(16):2884-96. PubMed ID: 20634380 [TBL] [Abstract][Full Text] [Related]
11. Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies. Laurencet FM; Zulian GB; Guetty-Alberto M; Iten PA; Betticher DC; Alberto P Br J Cancer; 1999 Mar; 79(7-8):1215-9. PubMed ID: 10098762 [TBL] [Abstract][Full Text] [Related]
13. Cladribine for the treatment of hematologic malignancies. Baltz JK; Montello MJ Clin Pharm; 1993 Nov; 12(11):805-13; quiz 860-2. PubMed ID: 7903917 [TBL] [Abstract][Full Text] [Related]
14. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia]. Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031 [TBL] [Abstract][Full Text] [Related]
19. Phase II trials of pentostatin (Nipent) in hairy cell leukemia. Kraut EH Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048 [TBL] [Abstract][Full Text] [Related]
20. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma. Beksaç M; Arat M; Idilman R Cancer; 1999 Jan; 85(1):242-3. PubMed ID: 9921999 [No Abstract] [Full Text] [Related] [Next] [New Search]